Jiankang Hu

Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial

Di Wu, Jing Li, Dong Xu et al. · Annals of the Rheumatic Diseases · 2023 · 140 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +8

Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial

Dong Xu, Jianmin Fang, Shangzhu Zhang et al. · Lara D. Veeken · 2023 · 72 citations

Medicine, Pharmacology, Pharmacotherapy +15

Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.

Zhanguo Li, Jiankang Hu, Chunde Bao et al. · PubMed · 2020 · 29 citations

Medicine, Internal Medicine, Pharmacotherapy +15

A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus

Ronald van Vollenhoven, Li Wang, Joan T. Merrill et al. · New England Journal of Medicine · 2025 · 26 citations

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study

Xiaomei Leng, Wei Lin, Shixue Liu et al. · RMD Open · 2023 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14